Cargando…
C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations
There are currently no accepted and validated blood tests available for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD). In this study, we sought to determine the discriminatory power of blood C-reactive protein (CRP) and N-terminal prohormone brain natriuretic pepti...
Autores principales: | Chen, Yu-wei Roy, Chen, Virginia, Hollander, Zsuzsanna, Leipsic, Jonathon A., Hague, Cameron J., DeMarco, Mari L., FitzGerald, J. Mark, McManus, Bruce M., Ng, Raymond T., Sin, Don D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362097/ https://www.ncbi.nlm.nih.gov/pubmed/28328968 http://dx.doi.org/10.1371/journal.pone.0174063 |
Ejemplares similares
-
Phenotyping COPD exacerbations using imaging and blood-based biomarkers
por: Alotaibi, Nawaf M, et al.
Publicado: (2018) -
Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples
por: Alotaibi, Nawaf M, et al.
Publicado: (2019) -
Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
por: Hoffmann, U, et al.
Publicado: (2004) -
Dissecting the correlates of N-terminal prohormone brain natriuretic peptide in acute infective endocarditis
por: Bertolino, Lorenzo, et al.
Publicado: (2022) -
COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
por: Leung, Janice M., et al.
Publicado: (2016)